What It Is:

ClinOps GPS is Reverba’s clinical engagement model for improving recruitment, retention, and study execution.

The model combines investigator development, site training and engagement, patient recruitment and pre-qualification, and in-trial experience measurement. All programs are delivered through the reverbaBRIDGE platform, enabling coordinated execution and real-time visibility across the trial ecosystem.

Why It Matters:

Recruitment delays, site variability, and participant dissatisfaction slows progress and increases risk. ClinOps GPS helps sponsors address these challenges through a structured engagement model that improves candidate flow, strengthens site responsiveness, and supports a better experience for participants throughout the study. 

How It Works:

ClinOps GPS activates investigators, sites, patients, and advocacy communities through a coordinated engagement model designed to support recruitment, retention, and trial readiness.

Powered by the reverbaBRIDGE platform, these programs connect site engagement, patient outreach, pre-qualification, and trial experience insights to reduce site burden and strengthen participation across the study.

Let’s talk about how ClinOps GPS can accelerate your clinical trials while improving the patient experience.


The Latest

  • From HBA GALE 2026: Why the Future of Healthcare Still Depends on Something Very Human
    From HBA GALE 2026: Why the Future of Healthcare Still Depends on Something Very Human

    Mentorship, community, and human-centered connection play a central role in shaping healthcare. While technology accelerates innovation, trust, collaboration, and human insight remain essential to advancing leadership, patient care, and organizational…

  • The Missing Moment: When Patient Voice Enters Strategy Too Late
    The Missing Moment: When Patient Voice Enters Strategy Too Late

    Patient insight often enters strategy after key decisions are already set, limiting its ability to shape evidence, positioning, and adoption. Introduced earlier, it informs the choices that drive differentiation, value…

  • How FDA Scrutiny and Patient Behavior Are Reshaping DTC’s Role in the US
    How FDA Scrutiny and Patient Behavior Are Reshaping DTC’s Role in the US

    DTC still drives awareness in the US, but it does not consistently support patient action on its own. FDA scrutiny and more complex patient journeys are shifting its role within…